[The effect of the delta sleep-inducing peptide on the development of toxic brain edema-swelling].
Platonov. I A IA; Iasnetsov. V V VV
Key Findings
- DSIP reduced toxic brain edema at 75‑100 µg/kg in the experimental model.
- The anti‑edema effect may involve inhibition of serotonin, noradrenaline, and histamine systems.
- Activation of the GABA‑ergic system by DSIP is also suggested as part of the mechanism.
Practical Outcomes
- For biohackers, this study offers little direct guidance. It shows DSIP can affect brain fluid balance in animals, but no human dosing or safety data are provided, so it isn’t ready for real‑world use in longevity or performance protocols.
Summary
Researchers tested delta sleep‑inducing peptide (DSIP) in a lab model of toxic brain swelling and found that doses of about 75‑100 µg per kilogram reduced the swelling, likely by dampening serotonin, noradrenaline and histamine signals while boosting GABA activity. The effect seems multi‑faceted and not fully understood.
Abstract
Antiedematic effects of the drugs are connected with their action on the mediator systems. DSIP has a wide range of modulatory effects on the brain mediator systems. DSIP antiedematic effect was studied on the toxic brain edema-swelling (BES) model. Physical characteristics of the nervous tissue such as thickness and wetness were used as evaluation criteria. According to the findings, the doses of 75-100 micrograms/kg DSIP were optimal. It is suggested that DSIP effect on BES is multicomponent and rather complicated. Inhibition of serotonin, noradrenaline and histamine systems and activation of GABA-ergic system by DSIP act as a possible antiedematic mechanism.
Study Information
pubmed
1992